Investment analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Sorrento Therapeutics stock opened at $0.00 on Tuesday. Sorrento Therapeutics has a 1-year low of $0.00 and a 1-year high of $0.25. The business has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.01.
About Sorrento Therapeutics
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- How to Most Effectively Use the MarketBeat Earnings Screener
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Airline Stocks – Top Airline Stocks to Buy Now
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.